Dr David Hallifax PhD CBiol CChem FRSB MRSC

Biography

After spending 10 years in contract research, responsible for metabolism and pharmacokinetic studies (ADME) for regulatory submission by major international companies (eg. Glaxo's Ondansetron for approval by JMHW, Japan, 1992), David studied for his PhD at Manchester (with Professor Brian Houston) and subsequently became a Research Fellow within the Centre for Applied Pharmacokinetic Research. David has done consultancy for pharmaceutical companies (eg. Vernalis's Frovatriptan ADME submission, 1998)

Qualifications

Bsc, PhD

Memberships of committees and professional bodies

Royal Society of Chemistry: Member, Chartered Chemist (MRSC, CChem)

Royal Society of Biology: Fellow, Chartered Biologist (FRSB, CBiol)

International Society for the Study of Xenobiotics